Hassan: Congress' duty to fund FDA

Share this article:
Schering-Plough chairman and CEO Fred Hassan has set out an agenda for the newly elected US Congress when it convenes in January.

In remarks to the Cardiovascular Summit of more than 150 cardiovascular experts in advance of the American Heart Association's annual Scientific Sessions, Hassan said the lawmakers have a “moral obligation” to play for the long term. 

Hassan called on the new Congress to recognize that biopharmaceutical research is vital to the success of the US economy.

Hassan said the key to sustaining biopharmaceutical research is to preserve the strength and independence of FDA.

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?